Seven Eight Capital LP Takes Position in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Seven Eight Capital LP bought a new stake in CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,556 shares of the biopharmaceutical company’s stock, valued at approximately $620,000. Other institutional investors and […]

Related Keywords

Canada , China , Janet Dorling , Piper Sandler , Sujal Shah , Cymabay Therapeutics Inc , Great West Life Assurance Co , Nasdaq , Royal Bank , China Universal Asset Management Co , Ameritas Investment Partners Inc , Securities Exchange Commission , Life Insurance Co , Cantor Fitzgerald , Exchange Commission , Seven Eight Capital , Cymabay Therapeutics , Free Report , Universal Asset Management , West Life Assurance , Ameritas Investment Partners , Bay Therapeutics , Get Free Report , Director Janet Dorling , Visit Holdingschannel , Cymabay Therapeutics Daily ,